http://health.einnews.com/news/acompliaConstantly updated news and information about healthcare industry. http://health.einnews.com/news.php?wid=191614889 6 Oct 2008 04:24 GMT ... an end the development the experimental obesity drug taranabant on account of its many adverse ... the same class of drugs as Sanofi-Aventis's Acomplia, a slimming pill for obesity treatment which didnt receive the Food and Drug ... http://health.einnews.com/news.php?wid=191503222 5 Oct 2008 04:45 GMT ... Mercks Anti-Obesity Drug Scrapped Due To Side Effects Submitted by ... not surprising. A drug on similar lines Acomplia, generically known as rimonabant, developed by France's Sanofi-Aventis SA had met ... http://health.einnews.com/news.php?wid=191462799 4 Oct 2008 20:57 GMT ... Long term if you stop taking this treatment or regimen. In deciding to use propecia ... and BREAST-FEEDING propecia photos before using the drug and other problems in humans the guarantee ... effects. It is not approved for the. Acomplia and go, back went away in men. ... http://health.einnews.com/news.php?wid=191403156 4 Oct 2008 12:00 GMT ... After lackluster results in a phase 3 trial, Merck has decided that it's just not ... high on its anti-obesity compound anymore. The drug, taranabant, inhibits the cannabinoid receptors in the ... risks -- witness Wyeth 's Fen-phen -- pharmaceutical companies seem to be running scared. Just ... http://health.einnews.com/news.php?wid=191398371 4 Oct 2008 11:18 GMT ... cancel further investigation into its experimental obesity drug called taranabant because of side effects uncovered ... 2007, Sanofi-Aventis anti-obesity drug, generically known as rimonabant (Acomplia) was also rejected by the Food and ... http://health.einnews.com/news.php?wid=191382454 4 Oct 2008 07:00 GMT ... ) is pulling plans to introduce anantiobesity drug. The New Jersey based company announced it ... stopping five current patient studies. In 2007, rimonabant, a drug made by Sanofi-Aventis (SNY) also ... AGs) and Meridia (Abbott Laboratories). Short term treatment for weight loss include alli ( GlaxoSmithKline) ... http://health.einnews.com/news.php?wid=191369565 4 Oct 2008 05:03 GMT ... halted the research of the experimental obesity drug taranabant because of the dangerous side effects ... the same class of drugs as Sanofi-Aventis's Acomplia, which didnt receive the Food and Drug ... suggested that the slimming pill for obesity treatment may augment the risk of suicide. It ... http://health.einnews.com/news.php?wid=191343008 4 Oct 2008 02:15 GMT ... has halted development of its investigational obesity drug taranabant. The New Jersey-based drugmaker has pulled ... great surprise, given the experience of Sanofi-Aventis Acomplia (rimonabant), which also blocks cannabinoid receptors in the ... http://health.einnews.com/news.php?wid=191291784 3 Oct 2008 15:35 GMT ... further development for obesity." Prospects for the drug did not look good, as there was ... and depressed mood. Taranabant is similar to rimonabant (Acomplia, Sanofi-Aventis), another cannabinoid antagonist currently on the ... http://health.einnews.com/news.php?wid=191291036 3 Oct 2008 15:31 GMT ... has stopped development of its experimental obesity drug taranabant after data in a late-stage clinical ... and depression, Merck spokeswoman Amy Rose said. Acomplia has been linked to suicidal thoughts and ... obesity. Taranabant and Acomplia, also known as rimonabant, work by blocking cannabinoid receptors in the ... http://health.einnews.com/news.php?wid=191288526 3 Oct 2008 15:06 GMT ... has stopped development of its experimental obesity drug taranabant after data in a late-stage clinical ... taranabant were psychiatric, including anxiety and depression. Acomplia has been linked to suicidal thoughts and ... depression. Taranabant and Acomplia, also known as rimonabant, work by blocking cannabinoid receptors in the ...